Global law firm Greenberg Traurig advised the company throughout the process. The offering drew significant institutional interest, with participation from firms including Adage Capital Partners, Nantahala Capital, Janus Henderson Investors, and RA Capital Management. Beyond the initial offering, AI Biotechnology LLC and Vianti Capital Fund I have signaled non-binding intent to participate in a future private placement tied to the company's eventual business combination.
JATT III Acquisition Corp Closes $69 Million Nasdaq IPO
With the full exercise of an overallotment option, JATT III Acquisition Corp raised $69 million in its initial public offering. The company issued 6.9 million ordinary shares priced at $10 each, securing a listing on the Nasdaq Capital Market under the ticker symbol JTTT starting August 26.
The legal team steering the transaction was led by Miami-based Vice Chair Alan I. Annex. He was supported by corporate shareholders Tricia Branker and Adam S. Namoury, along with associate Tiange Chen and law clerk Jung Baek. This capital raise marks a notable entry for JATT III into the public markets as it looks toward its first business combination.
Comments (0)
No comments yet. Be the first!